S&P Global Ratings assigned its ‘AA+/A-1+’ dual rating to Maryland Health and Higher Educational Facilities Authority series 2026B-1 variable-rate demand revenue bonds, issued for University of Maryland Medical System (UMMS). At the same time, we assigned our ‘AA+/A-1’ rating to the authority’s series 2026B-2 and our ‘AA/A-1’ to the authority’s series 2026B-3 variable-rate demand revenue bonds, issued for UMMS. Finally, S&P Global Ratings assigned its'A'underlying rating (SPUR) to the authority’s series 2026B-1, 2026B-2, and 2026B-3 variable-rate demand revenue bonds, issued for UUMS. The outlook on the SPUR is stable. A revenue pledge of the obligated group secures the bonds. The obligated group includes all of UMMS'wholly owned acute-care hospitals and one foundation. Nonobligated members include its owned
